Kraig Biocraft Financials
| KBLB Stock | USD 0.09 0.0001 0.11% |
With this module, you can analyze Kraig financials for your investing period. You should be able to track the changes in Kraig Biocraft individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Kraig |
Understanding current and past Kraig Biocraft Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Kraig Biocraft's financial statements are interrelated, with each one affecting the others. For example, an increase in Kraig Biocraft's assets may result in an increase in income on the income statement.
The data published in Kraig Biocraft's official financial statements typically reflect Kraig Biocraft's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Kraig Biocraft's quantitative information. For example, before you start analyzing numbers published by Kraig accountants, it's essential to understand Kraig Biocraft's liquidity, profitability, and earnings quality within the context of the Chemicals space in which it operates.
Please note, the presentation of Kraig Biocraft's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kraig Biocraft's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kraig Biocraft's management manipulating its earnings.
Kraig Biocraft Stock Summary
Kraig Biocraft competes with Symrise Ag, Novozymes, International Flavors, Air Products, and Oil Dri. Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US50075W1045 |
| Business Address | 2723 South State |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | www.kraiglabs.com |
| Phone | 734 619 8066 |
| Currency | USD - US Dollar |
Kraig Biocraft Key Financial Ratios
Kraig Biocraft's financial ratios allow both analysts and investors to convert raw data from Kraig Biocraft's financial statements into concise, actionable information that can be used to evaluate the performance of Kraig Biocraft over time and compare it to other companies across industries.Kraig Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kraig Biocraft's current stock value. Our valuation model uses many indicators to compare Kraig Biocraft value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kraig Biocraft competition to find correlations between indicators driving Kraig Biocraft's intrinsic value. More Info.Kraig Biocraft Labs is rated below average in return on asset category among its peers. It also is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kraig Biocraft by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kraig Biocraft's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kraig Biocraft Labs Systematic Risk
Kraig Biocraft's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kraig Biocraft volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Kraig Biocraft Labs correlated with the market. If Beta is less than 0 Kraig Biocraft generally moves in the opposite direction as compared to the market. If Kraig Biocraft Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kraig Biocraft Labs is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kraig Biocraft is generally in the same direction as the market. If Beta > 1 Kraig Biocraft moves generally in the same direction as, but more than the movement of the benchmark.
Kraig Biocraft November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kraig Biocraft help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kraig Biocraft Labs. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kraig Biocraft Labs based on widely used predictive technical indicators. In general, we focus on analyzing Kraig OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kraig Biocraft's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.05 | |||
| Information Ratio | (0.0007) | |||
| Maximum Drawdown | 23.61 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 11.11 |
Complementary Tools for Kraig OTC Stock analysis
When running Kraig Biocraft's price analysis, check to measure Kraig Biocraft's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kraig Biocraft is operating at the current time. Most of Kraig Biocraft's value examination focuses on studying past and present price action to predict the probability of Kraig Biocraft's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kraig Biocraft's price. Additionally, you may evaluate how the addition of Kraig Biocraft to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |